PR NEWSWIRE

Previous Stories

Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer’s disease trial

Dec 10 2024 - PR NewsWire

Late-stage trial in Alzheimer’s opens 10 sites in US, with results due in 2025 and 2026 Appoints US-based Chief Commercial…


LONGi and Raystech Announce Exclusive Strategic Partnership to Transform Australia’s Solar Market

Dec 09 2024 - PR NewsWire

XI’AN, China, Dec. 9, 2024 /PRNewswire/ — On November 25, Raystech Group Pty. Ltd. ("Raystech"), one of Australia’s leading photovoltaic distributors,…


Gift Cards Take Center Stage This Christmas: Australian Shoppers to Spend Nearly Half of Gift Budget on Flexible Presents

Dec 09 2024 - PR NewsWire

MELBOURNE, Australia, Dec. 9, 2024 /PRNewswire/ — According to new research[1] from global branded payment provider, Blackhawk Network (BHN), Aussie consumers…


Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator

Dec 06 2024 - PR NewsWire

– VIEH Singapore’s Duc Hoa 3 Industrial Park Selected as Premier Location MELBOURNE, Australia, Dec. 6, 2024 /PRNewswire/ — Core8…


KANEKA UBIQUINOL™ AWARDED PRESTIGIOUS COMPLEMENTARY MEDICINES AUSTRALIA RAW MATERIAL SUPPLIER OF THE YEAR AWARD 2024

Dec 06 2024 - PR NewsWire

SYDNEY, Dec. 6, 2024 /PRNewswire/ — Kaneka Ubiquinol™ has been awarded the coveted Raw Material Supplier of the Year Award…


DDPAI Partners with Battery World to Bring Smarter Dashcam Solutions to Australian Drivers

Dec 06 2024 - PR NewsWire

SYDNEY, Dec. 6, 2024 /PRNewswire/ – DDPAI, a global leader in dashcam innovation, is proud to announce its partnership with Battery…


IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-Quality Proteomic Insights

Dec 06 2024 - PR NewsWire

MELBOURNE, Australia and ZURICH, Dec. 6, 2024 /PRNewswire/ – Today, IonOpticks, a world leading provider of chromatography solutions, and Biognosys, a global…


CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial

Dec 05 2024 - PR NewsWire

MELBOURNE, Australia, Dec. 5, 2024 /PRNewswire/ — Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company…


Former CSL CEO Paul Perreault appointed strategic adviser to Microbio

Dec 05 2024 - PR NewsWire

Establishing sepsis diagnostic InfectID™ as the new standard of care BRISBANE, Australia, Dec. 5, 2024 /PRNewswire/ — Microbio Ltd, the Australian pathogen…


Applus+ in Australia partners with Abyss Solutions to revolutionize Non-Destructive Testing with Artificial Intelligence

Dec 05 2024 - PR NewsWire

HOUSTON, Dec. 5, 2024 /PRNewswire/ — Applus+, a global leader in the Inspection, Testing and Certification sector, is pleased to…


Analyse The Market From A Different Angle